CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Open-market sale 10% owner sold 29,464 shares at $10.60 ($312,318)
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Delisting notice
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 21 of 24 · 479 filings